| pubmed-article:18684538 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18684538 | lifeskim:mentions | umls-concept:C0162791 | lld:lifeskim |
| pubmed-article:18684538 | lifeskim:mentions | umls-concept:C0444454 | lld:lifeskim |
| pubmed-article:18684538 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:18684538 | pubmed:dateCreated | 2008-8-15 | lld:pubmed |
| pubmed-article:18684538 | pubmed:abstractText | The Organisation for Economic Co-operation and Development (OECD) has published a new set of principles and guidelines to promote open access to datasets and results from publicly funded research. However, there is reason to think twice about the implications of making demands for transparency and open access for publicly funded research only. How will such demands affect incentives and research agendas? Might this new regulation of publicly funded research have undesirable effects on the quality and value of research? Placing the OECD guidelines in a broader context of research regulation, we argue that they might provide a further push toward collaboration with commercially sponsored research and reinforce incentive structures that favour the creation of commercial value. | lld:pubmed |
| pubmed-article:18684538 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18684538 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18684538 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18684538 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18684538 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:18684538 | pubmed:issn | 0167-7799 | lld:pubmed |
| pubmed-article:18684538 | pubmed:author | pubmed-author:HoeyerKlausK | lld:pubmed |
| pubmed-article:18684538 | pubmed:author | pubmed-author:KochLeneL | lld:pubmed |
| pubmed-article:18684538 | pubmed:author | pubmed-author:SvendsenMette... | lld:pubmed |
| pubmed-article:18684538 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18684538 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:18684538 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18684538 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18684538 | pubmed:pagination | 479-82 | lld:pubmed |
| pubmed-article:18684538 | pubmed:meshHeading | pubmed-meshheading:18684538... | lld:pubmed |
| pubmed-article:18684538 | pubmed:meshHeading | pubmed-meshheading:18684538... | lld:pubmed |
| pubmed-article:18684538 | pubmed:meshHeading | pubmed-meshheading:18684538... | lld:pubmed |
| pubmed-article:18684538 | pubmed:meshHeading | pubmed-meshheading:18684538... | lld:pubmed |
| pubmed-article:18684538 | pubmed:meshHeading | pubmed-meshheading:18684538... | lld:pubmed |
| pubmed-article:18684538 | pubmed:meshHeading | pubmed-meshheading:18684538... | lld:pubmed |
| pubmed-article:18684538 | pubmed:meshHeading | pubmed-meshheading:18684538... | lld:pubmed |
| pubmed-article:18684538 | pubmed:meshHeading | pubmed-meshheading:18684538... | lld:pubmed |
| pubmed-article:18684538 | pubmed:meshHeading | pubmed-meshheading:18684538... | lld:pubmed |
| pubmed-article:18684538 | pubmed:meshHeading | pubmed-meshheading:18684538... | lld:pubmed |
| pubmed-article:18684538 | pubmed:meshHeading | pubmed-meshheading:18684538... | lld:pubmed |
| pubmed-article:18684538 | pubmed:meshHeading | pubmed-meshheading:18684538... | lld:pubmed |
| pubmed-article:18684538 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18684538 | pubmed:articleTitle | OECD guidelines on open access: commercialization in disguise? | lld:pubmed |
| pubmed-article:18684538 | pubmed:affiliation | Department of Health Services Research, Institute of Public Health, University of Copenhagen, Øster Farimagsgade 5, Building 15, DK-1014 Copenhagen K, Denmark. k.hoeyer@pubhealth.ku.dk | lld:pubmed |
| pubmed-article:18684538 | pubmed:publicationType | Journal Article | lld:pubmed |
